(Q42247622)

19 October 2017

title

Double-blind randomized crossover trial of verapamil and propranolol in chronic stable angina (English)

1 reference

Cardiology and cardiovascular medicine

19 October 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

7 October 2023

author name string

M. J. Bowles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6359843

7 October 2023

V. Bala Subramanian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6359843

7 October 2023

A. B. Davies

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6359843

7 October 2023

E. B. Raftery

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6359843

7 October 2023

language of work or name

English

0 references

publication date

1 December 1983

1 reference

full work available at URL

19 October 2017

https://api.elsevier.com/content/article/PII:0002870383900376?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

https://api.elsevier.com/content/article/PII:0002870383900376?httpAccept=text/plain

7 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

7 October 2023

published in

American Heart Journal

1 reference

19 October 2017

volume

106

1 reference

19 October 2017

issue

6

1 reference

19 October 2017

page(s)

1297-1306

1 reference

Propranolol in the treatment of angina: a review

19 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Double-blind Evaluation of Verapamil, Propranolol, and Isosorbide Dinitrate against a Placebo in the Treatment of Angina Pectoris

7 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests

7 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Propranolol in angina pectoris: Duration of improved exercise tolerance and circulatory effects after acute oral administration

7 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Comparative effects of verapamil and propranolol in patients with angina pectoris

7 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Introduction: Calcium channel blockers

7 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Drugs and the heart. III. Calcium antagonists

7 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Verapamil in ischaemic heart disease--quantitative assessment by serial multistage treadmill exercise

7 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise

7 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Clinical and experimental use of thoracic impedance plethysmography in quantifying myocardial contractility

7 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Evaluation of Impedance Cardiography as a Non-Invasive Means of Measuring Systolic Time Intervals and Cardiac Output

7 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Electrical impedance cardiogram in derivation of systolic time intervals

7 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Alterations in left ventricular function in normal man on exposure to high altitude (3658 m)

7 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Effect of digoxin and diuretics on high altitude left ventricular dysfunction

7 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

The medical treatment of angina pectoris II. Design of an antianginal drug study

7 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Prognosis of new and worsening angina pectoris

7 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients

7 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Importance of the Design of an Exercise Protocol in the Evaluation of Patients with Angina Pectoris

7 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Should placebo-controlled trials be abolished?

7 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Adaptation to exercise in angina pectoris. The electrocardiogram during treadmill walking and coronary angiographic findings

7 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit

7 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Verapamil in angina: a double-blind trial

7 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Clinical evaluation of verapamil in angina pectoris.

7 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Double blind evaluation of orally administered iproveratril in patients with angina pectoris

7 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

7 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Hemodynamic correlates of myocardial oxygen consumption during upright exercise

7 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Coronary circulation during heavy exercise in control subjects and patients with coronary heart disease

7 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

The spherical dynamics of the heart (myocardial tension, oxygen consumption, coronary blood flow and efficiency)

7 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

Velocity of contraction as a determinant of myocardial oxygen consumption

7 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-8703(83)90037-6

7 October 2023

Identifiers

1 reference

19 October 2017

1 reference